Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data

Author(s): Adrian Wagg

Overactive bladder is a common and troublesome condition for many older people. Although the first-line treatment for the condition is with behavioral and lifestyle measures, many older people will require pharmacological therapy to successfully manage their condition. Fesoterodine, a relatively new antimuscarinic agent for the treatment of overactive bladder, has been extensively trialed in older people and is associated with a significant improvement in both disease related outcomes and in quality of life. Fesoterodine also appears to be well tolerated in this older group of patients. This review discusses the available evidence for fesoterodine in older people to date.